Tuberculosis Vaccine Market Growth Accelerated By Tuberculosis Vaccine Pipeline Development
![]() |
Tuberculosis Vaccine Market |
Tuberculosis (TB) is a bacterial infection caused by
Mycobacterium tuberculosis that typically affects the lungs. It is transmitted
from person to person via droplets from the throat and lungs of people with the
active respiratory disease. Tuberculosis vaccine aims to protect, prevents
spreading of the bacteria that causes tuberculosis disease. The existing TB
vaccine Bacillus Calmette-Guérin (BCG) provides limited and variable protection
against adult pulmonary TB and has no efficacy against latent TB infection or
reactivation disease. Over the years, steady progress is being made in the
development of new TB vaccines with improved efficacy and the global
tuberculosis vaccine market is witnessing significant growth. The global
Tuberculosis Vaccine Market is estimated to be valued at US$ 149.67 Mn in 2023
and is expected to exhibit a CAGR of
21.% over the forecast period 2023 to 2030, as highlighted in a new report
published by Coherent Market Insights.
Market key trends:
New tuberculosis vaccine pipeline development is significantly driving the
market growth. As per recent studies, there are 11 candidate TB vaccines in the
clinical pipeline and over 30 candidate vaccines in preclinical development.
Major players are increasingly investing in R&D of new generation vaccines
to replace the existing BCG vaccine. For instance, the most advanced candidate
vaccine, M72/AS01E, developed by GlaxoSmithKline, is currently in phase III
clinical trials. If approved, it would be the first new TB vaccine in over 100
years. The robust pipeline with novel mechanism of actions and improved
immunogenicity hold potential to significantly boost the market in coming
years.
Segment
Analysis
Tuberculosis
is caused by harmful bacteria that usually attack the lungs. It can affect any
organ in the body. The tuberculosis vaccine market is segmented based on
disease indication as latent tuberculosis and active tuberculosis. The latent
tuberculosis indication dominates the market currently owing to large
population globally diagnosed with latent tuberculosis. Latent tuberculosis has
no or very minimal symptoms and does not spread to other people. However,
persons with latent tuberculosis have TB bacteria in their body and thus are at
high risk of developing active TB disease in future if not treated.
Key Takeaways
The global
tuberculosis vaccine market analysis is expected to witness high growth
over the forecast period.
Regional analysis shows that Asia Pacific region currently
dominates the market and is expected to maintain its dominance during the
forecast period. Countries like India, China, Indonesia have high burden of
tuberculosis cases accounting for over 60% of global total. These developing
economies present significant growth opportunities for tuberculosis vaccine
market players owing to government initiatives, increasing awareness and
healthcare investments.
Key players operating in the tuberculosis vaccine market are Fujitsu Limited,
Mindtree Limited, IBM Corporation, Wipro Limited, Unisys Corporation,
CenturyLink Inc., Virtustream Inc. and HCL Technologies Limited. These
companies are involved in developing and manufacturing new TB vaccines. They
are focusing on R&D activities to develop novel vaccines with improved
efficacy and longer lasting immunity. Partnerships and collaborations between
research institutes and market players are also expected to boost market
growth.
Get more insights on this topic: https://www.newswirestats.com/tuberculosis-vaccine-market-industry-insights-trends-tuberculosis-vaccine-market/
Explore more information on this topic, Please visit: https://wotpost.com/optical-transceivers-enabling-high-speed-data-transmission/
Comments
Post a Comment